- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02742220
Isometric Handgrip Training on Blood Pressure of Peripheral Artery Disease Patients
February 1, 2018 updated by: Raphael M. Ritti Dias, University of Pernambuco
Effects of Isometric Handgrip Training on Blood Pressure Reduction in Patients With Peripheral Artery Disease: A Randomized Clinical Trial
The aim of this study is to analyze the effects of isometric handgrip training (IHT) on blood pressure of hypertensive patients with peripheral arterial disease.
Will be recruited 60 patients which will be randomized into 2 groups (30 per group), IHT and control group (CG).
IHT group will training isometric contraction for 8 weeks.
The GC patients will be encouraged to increase the level of physical activity.
In the pre and post-intervention, brachial and central blood pressure will be measured.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Meta-analyze studies have shown that IHT promotes reductions in blood pressure (BP), reaching 10 mmHg for systolic and diastolic 7 mmHg.
However, remain uncertain the effects of this type of training on BP in patients with more severe cardiovascular diseases such as peripheral artery disease.
Because this type of training which requires approximately 20 minutes per session and does not require supervision, it is possible that this intervention is interesting to reduce BP of these patients.
The aim of this study is to analyze the effects of IHT on blood pressure of hypertensive patients with peripheral arterial disease.
Will be recruited 60 patients, which will be randomized into 2 groups (30 per group), IHT and control group (CG).
IHT group will hold three sessions per week with four unilateral sets with two minutes of isometric contraction at 30% of maximal voluntary contraction and interval of four minutes between them, for 8 weeks.
The GC patients will be encouraged to increase the level of physical activity.
In the pre and post-intervention, is going to be evaluated functional capacity, brachial and central BP, arterial stiffness, cardiovascular autonomic modulation and muscle vasodilation.
Will be used to analyze two-factor variance for repeated measures, with group (IHT and GC) and the time (before and after 8 weeks) as factors and the post-hoc test of Newman-Keuls.
Study Type
Interventional
Enrollment (Actual)
102
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
São Paulo, Brazil, 05652-900
- Israel Institute of Education and Research Albert Einstein
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- postmenopausal without hormone therapy replacement, if woman;
- present peripheral artery disease (ankle brachial index < 0.90) in one or both lower limbs;
- do not present neurological / cognitive diseases;
- is able to practice home-based exercise;
Exclusion Criteria:
- patients will only be excluded if they make any medication changes before completing the intervention period or present any health problems that prevent physical activity.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Isometric Handgrip Training Group
Experimental group will perform home-based unilateral handgrip exercise and will be recommended to increase daily physical activity levels.
|
Intervention period will last eight weeks.
Experimental group will perform three sessions per week of home-based handgrip exercise.
The exercise protocol will consist of four unilateral sets (dominant arm) with two minutes of isometric contraction, with 30% of maximum voluntary contraction, and four minutes of interval between sets.
Patients will receive a diary to record the sessions and report difficulties during the training.
Visits will be scheduled at weeks 1 and 5 to provide feedback to individuals, discuss possible problems during the training and adjust the intensity of the exercise.
In addition the patients be recommended to increase daily physical activity levels, and weekly, there will be phone contacts with the patients to reinforce the exercise recommendations.
Other Names:
|
Sham Comparator: Control Group
Control group will be recommended to increase daily physical activity levels.
|
Intervention period will last eight weeks.
Patients will be recommended to increase daily physical activity levels, and weekly, there will be phone contacts to reinforce the recommendations.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in blood pressure at eight weeks
Time Frame: Baseline and eight weeks
|
Blood pressure will be measured before and after eight weeks of intervention period on intervention and control group by an automatic blood pressure monitor (HEM-742, Omron Healthcare, Japan).
|
Baseline and eight weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in autonomic cardiac modulation at eight weeks
Time Frame: Baseline and eight weeks
|
Cardiac autonomic modulation will be measured before and after eight weeks of intervention period on intervention and control group by heart rate monitor (Polar, RS 800, USA).
|
Baseline and eight weeks
|
Change from baseline in vasodilatory capacity at eight weeks
Time Frame: Baseline and eight weeks
|
Vasodilatory capacity will be measured before and after eight weeks of intervention period on intervention and control group by a flow mediated dilation measurement with an ultrasound image (HDI 5000 Sono CT, Philips, The Netherlands).
|
Baseline and eight weeks
|
Change from baseline in arterial stiffness at eight weeks
Time Frame: Baseline and eight weeks
|
Arterial stiffness will be measured before and after eight weeks of intervention period on intervention and control group by pulse wave velocity measurement with applanation tonometry (SphygmoCor, AtCor Medical, Australia).
|
Baseline and eight weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Raphael Ritti-Dias, PhD, Israel Institute of Education and Research Albert Einstein
- Study Director: Gabriel Cucato, PhD, Israel Institute of Education and Research Albert Einstein
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2016
Primary Completion (Actual)
December 1, 2017
Study Completion (Actual)
December 1, 2017
Study Registration Dates
First Submitted
April 4, 2016
First Submitted That Met QC Criteria
April 15, 2016
First Posted (Estimate)
April 18, 2016
Study Record Updates
Last Update Posted (Actual)
February 5, 2018
Last Update Submitted That Met QC Criteria
February 1, 2018
Last Verified
February 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IHT PAD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
IPD Plan Description
The IPD data to be shared are the indivividual and mean data of blood pressure responses to eight weeks of isometric handgrip training.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Artery Disease
-
Janssen Scientific Affairs, LLCHCA Research Institute, LLCRecruitingCoronary Artery Disease (CAD) | Peripheral Artery Disease (PAD)United States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedStructural Heart Disease | Obstructive Coronary Artery Disease | Obstructive Peripheral Artery DiseaseUnited States
-
Michael Lichtenberg, MDCompletedPeripheral Artery Disease (PAD)Germany
-
Helsinki University Central HospitalCompletedPeripheral Artery Occlusive Disease | Peripheral Artery Stenosis | Peripheral Artery RestenosisFinland
-
Fangge DengRecruitingPeripheral Artery Disease (PAD)China
-
Fundacion para la Formacion e Investigacion Sanitarias...Not yet recruiting
-
Rontis Hellas SAPharmassist LtdActive, not recruitingPeripheral Artery Disease (PAD)Greece
-
Boston Scientific CorporationCompletedAtherosclerosis | Peripheral Artery Disease | Plaque, Atherosclerotic | Artery Diseases, Peripheral | Occlusive Arterial DiseaseUnited States, Belgium, Canada, Japan, Austria, New Zealand
-
Seung-Whan Lee, M.D., Ph.D.Active, not recruitingCatheterization, Peripheral | Popliteal Artery | Angioplasty, Balloon | Femoral ArteryKorea, Republic of
-
Dartmouth-Hitchcock Medical CenterSociety for Vascular SurgeryCompletedPeripheral Artery Disease (PAD)United States
Clinical Trials on Isometric Handgrip Training Group
-
University of Nove de JulhoHospital Israelita Albert EinsteinRecruitingPeripheral Arterial DiseaseBrazil
-
University of Massachusetts, BostonNot yet recruiting
-
University of PernambucoCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Fundação de Amparo... and other collaboratorsCompleted
-
KU LeuvenResearch Foundation FlandersCompleted
-
University Institute of MaiaUniversity of Connecticut; Aveiro University; Hospital Infante D. Pedro, Centro... and other collaboratorsCompletedHypertension | Pre-HypertensionUnited States, Portugal
-
Universidade Federal de Santa CatarinaConselho Nacional de Desenvolvimento Científico e TecnológicoRecruiting
-
University of NottinghamThe Royal College of Surgeons of England; The Dunhill Medical TrustUnknownHypertension | Perioperative HypertensionUnited Kingdom
-
Instituto de Cardiologia do Rio Grande do SulRecruitingArterial HypertensionBrazil
-
Riphah International UniversityRecruitingHealthy AdolescentsPakistan
-
Swansea UniversityNational Taiwan Normal UniversityRecruitingBlood PressureTaiwan, United Kingdom